Setting 
My Cart

Ordered before 17:30, shipped today - Support: (012) 800 456 789

Track Your Order

Toggle Nav
mobile icon
Close
  • Menu
  • Setting
  • Home
  • Search results for: 'cy5 maleimide non sulfonated 5mg'

Search results for: 'cy5 maleimide non sulfonated 5mg'

Items 111-120 of 173

Page
per page
  1. Nu 6027
    A1986 Nu 6027
    Target: Cyclin-Dependent Kinases|ATM/ATR
    Summary: ATR/CDK inhibitor, potent and selective
      insoluble in H2O; ≥12.55 mg/mL
  2. SLx-2119
    A3825 SLx-2119
     1 Citation
    Target: ROCK
    Summary: Selective ROCK2 inhibitor
      ≥22.65 mg/mL
  3. ARRY 520 trifluoroacetate
    A4458 ARRY 520 trifluoroacetate
    Summary: KSP inhibitor
      Soluble in DMSO
  4. HMN-214
    A5413 HMN-214
    Summary: Plk inhibitor,broad-spectrum anti-tumor agent
      ≥21.2 mg/mL
  5. PHA-848125
    A8501 PHA-848125
    Target: Cyclin-Dependent Kinases
    Summary: CDK inhibitor,potent and ATP-competitive
      ≥23.05 mg/mL
  6. Verdinexor (KPT-335)
    B4889 Verdinexor (KPT-335)
    Summary: XPO1/CRM1 inhibitor
      ≥44.2 mg/mL
  7. GSK-923295
    A3450 GSK-923295
     1 Citation
    Summary: CENP-E inhibitor,small-molecule
      ≥29.6 mg/mL
  8. ENMD-2076 L-(+)-Tartaric acid
    A4129 ENMD-2076 L-(+)-Tartaric acid
    Summary: Aurora kinases inhibitor
      insoluble in EtOH; ≥175.8 mg/mL
  9. CDK inhibitor II
    A3293 CDK inhibitor II
    Summary: CDK inhibitor
      Soluble in DMSO
  10. CFI-400945
    C5813 CFI-400945
    Summary: orally available, selective inhibitor of polo-like kinase 4 (PLK4)
      insoluble in H2O; ≥109.8 mg/mL

Items 111-120 of 173

Page
per page
Shop By
Now Shopping by
  1. Category Cell Cycle/Checkpoint Remove This Item
Clear All
Shopping Options
Category
  1. ATM/ATR 4item
  2. Aurora Kinase 22item
  3. Cdc42 3item
  4. Cdc7 1 item
  5. Chk 10item
  6. c-Myc 3item
  7. CRM1 2item
  8. Cyclin-Dependent Kinases 52item
  9. E1 enzyme 1 item
  10. G-quadruplex 3item
  11. Haspin 1 item
  12. HMTase 1 item
  13. Kinesin 6item
  14. Ksp 3item
  15. Microtubule/Tubulin 18item
  16. Mps1 2item
  17. Mitotic 1 item
  18. RAD51 1 item
  19. ROCK 8item
  20. Rho 7item
  21. PAK1 4item
  22. PAK4 1 item
  23. PERK 3item
  24. PLK 15item
  25. Wee1 1 item
Specificity
  1. Selective 54item
Reversibility
  1. Reversible 5item
  2. Irreversible 1 item
Target
  1. Cyclin-Dependent Kinases 22item
  2. PI3K 2item
  3. Aurora Kinases 15item
  4. mTOR 1 item
  5. FLT3 4item
  6. GSK-3 1 item
  7. PLK 9item
  8. Chk 7item
  9. PDGFR 1 item
  10. RET 1 item
  11. Bromodomain-containing proteins(BRDs) 1 item
  12. MEK 1 item
  13. FGFR 1 item
  14. Voltage-gated Sodium (NaV) Channels 1 item
  15. Src 3item
  16. Microtubules/Tubulins 3item
  17. ROCK 4item
  18. PAK 2item
  19. JAK 1 item
  20. DNA-PK 1 item
  21. Ksp 2item
  22. RAD51 1 item
  23. LRRK2 1 item
  24. ATM/ATR 3item
  25. G-quadruplexes 1 item
  26. Hck 1 item
  27. Ubiquitin-activating Enzyme E1 1 item
  28. Microtubule/Tubulin 3item
  29. VEGFR3/FLT4 1 item
  30. NTRK1/TRKA 1 item
  31. CSF-1R/c-Fms 1 item
  32. Hec1 1 item
  33. Lck 1 item
  34. FGR 1 item
  35. YES 1 item
  36. Fyn 1 item
  37. ARG 1 item
  38. ATM 1 item
Reported Experiments
  1. Animal Experiments 60item
  2. Cell Experiments 46item
Related Disease
  1. Acute Myeloid Leukemia 5item
  2. B-lymphoid Malignancies 1 item
  3. Breast Cancer 13item
  4. Cancer 55item
  5. Cervical Cancer 1 item
  6. Chronic Lymphocytic Leukemia 2item
  7. Colon Cancer 8item
  8. Colorectal Cancer 4item
  9. Glioblastoma 1 item
  10. Leukemia 1 item
  11. Liver Cancer 1 item
  12. Lung Cancer 3item
  13. Lymphoma 4item
  14. Mantle Cell Lymphoma 1 item
  15. Melanoma 2item
  16. Multiple Myeloma 1 item
  17. Neuroblastoma 1 item
  18. Non-small Cell Lung Carcinoma 1 item
  19. Ovarian Cancer 8item
  20. Pancreatic Cancer 6item
  21. Prostate Cancer 4item